Mark K. Ferguson, MD

home / authors / mark-k-ferguson-md

Articles

Concomitant Cisplatin, Vinorelbine, and Radiation in Advanced Chest Malignancies

Gregory A. Masters, MD;Stuart A. Krauss, MD;Harvey M. Golomb, MD;Daniel J. Haraf, MD;Philip C. Hoffman, MD;Mark K. Ferguson, MD;Jemi Olak, MD;Everett E. Vokes, MD

October 2nd 1997

Newer chemotherapy drugs have shown encouraging activity in advanced non-small-cell lung cancer. Based on these improved outcomes, as well as the high rate of distant relapse in patients with locally advanced disease, several recent studies have evaluated the use of systemic therapy in patients with earlier-stage disease.

Esophageal Cancer Surgical Practice Guidelines

Robert Ginsberg, MD;Jack A. Roth, MD, FACS;Mark K. Ferguson, MD

July 1st 1997

The Society of Surgical Oncology surgical practice guidelines focus on the signs and symptoms of primary cancer, timely evaluation of the symptomatic patient, appropriate preoperative extent of disease evaluation, and the role of the surgeon in

Lung Cancer Surgical Practice Guidelines

Robert Ginsberg, MD;Jack A. Roth, MD, FACS;Mark K. Ferguson, MD

June 1st 1997

The Society of Surgical Oncology surgical practice guidelines focus on the signs and symptoms of primary cancer, timely evaluation of the symptomatic patient, appropriate preoperative evaluation for extent of disease, and role of the surgeon in